WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2014200211) LIQUID PHARMACEUTICAL COMPOSITION CONTAINING PIROXICAM AND HYALURONIC ACID FOR THE TREATMENT OF OSTEOARTHRITIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/200211    International Application No.:    PCT/KR2014/004745
Publication Date: 18.12.2014 International Filing Date: 27.05.2014
IPC:
A61K 31/54 (2006.01), A61K 31/728 (2006.01), A61P 19/02 (2006.01), A61P 19/00 (2006.01)
Applicants: DONG-A ST CO., LTD [KR/KR]; (Yongdoo-dong) 64, Cheonho-daero Dongdaemun-gu Seoul 130-823 (KR)
Inventors: KIM, Soon-Hoe; (KR).
SON, Mi-Won; (KR).
JANG, Sun-Woo; (KR).
PARK, Chan-Woong; (KR).
MA, Kyung-Wan; (KR).
JUNG, Sang-Won; (KR)
Agent: ROH, Jae-Chull; WAY with ROH Patent & Law Office, 4F, 30 (Yeoksam-dong, Halla Building) 25-gil, Teheran-ro Gangnam-gu Seoul 135-909 (KR)
Priority Data:
10-2013-0067792 13.06.2013 KR
Title (EN) LIQUID PHARMACEUTICAL COMPOSITION CONTAINING PIROXICAM AND HYALURONIC ACID FOR THE TREATMENT OF OSTEOARTHRITIS
(FR) COMPOSITION PHARMACEUTIQUE LIQUIDE CONTENANT DU PIROXICAM ET DE L'ACIDE HYALURONIQUE POUR LE TRAITEMENT DE L'ARTHROSE
Abstract: front page image
(EN)The present invention relates to the pharmaceutical composition for the treatment of osteoarthritis comprising piroxicam or pharmaceutically acceptable salt thereof and hyaluronic acid or pharmaceutically acceptable salt thereof at a specific ratio that generates synergistic effect on both anti-inflammatory and analgesic effects simultaneously. The present invention provides a pharmaceutical composition for the treatment of osteoarthritis comprising 0.25-10.0 wt% of piroxicam or its pharmaceutically acceptable salt and 0.5-5.0 wt% of hyaluronic acid or its pharmaceutically acceptable salt, where the weight ratio between piroxicam or its pharmaceutically acceptable salt and hyaluronic acid or its pharmaceutically acceptable salt is between 1:1 and 1:3. The liquid pharmaceutical composition according to the present invention has an outstanding therapeutic effect simultaneously on both inflammation and pain, thus providing an injectable formulation for intra-articular injection with synergistic effect on the treatment of osteoarthritis.
(FR)La présente invention concerne la composition pharmaceutique de traitement de l'arthrose, qui comprend du piroxicam ou un sel pharmaceutiquement acceptable de ce dernier, et de l'acide hyaluronique ou un sel pharmaceutiquement acceptable de ce dernier, à un taux spécifique qui génère un effet synergique simultanément sur des effets anti-inflammatoires et analgésiques. La présente invention concerne une composition pharmaceutique de traitement de l'arthrose, comprenant de 0,25 à 10,0 % en poids de piroxicam ou d'un sel pharmaceutiquement acceptable de celui-ci et de 0,5 à 5,0 % en poids d'acide hyaluronique ou de son sel pharmaceutiquement acceptable, le rapport de poids entre le piroxicam ou son sel pharmaceutiquement acceptable et l'acide hyaluronique ou son sel pharmaceutiquement acceptable étant compris entre 1:1 et 1:3. La composition pharmaceutique liquide selon la présente invention a un incroyable effet thérapeutique simultanément sur une inflammation et une douleur, en créant ainsi une formulation injectable pour une injection intra-articulaire ayant un effet synergique sur le traitement d'arthrose.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)